Lymphoma | Norton Healthcare

Indication: Lymphoma

Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells

Sub-indication: Hematological Malignancies

Study Type: Specimen Study

Principal Investigator: Don Stevens, M.D.
Norton Cancer Institute

Sponsor: Sponsor: Celgene

Learn more at ClinicalTrials.gov

Email for more information: Heme-NCIResearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.